News - 03 Feb `20Emerging drugs for the treatment of vitiligo

New

Our co-authored paper titled Emerging drugs for the treatment of vitiligo has been published in the journal Expert Opinion on Emerging Drugs.

This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treatment in current research, followed by antioxidant and repigmenting mechanisms, basic fibroblast growth factors, afamelanotide and targeted immunotherapy.

For more information about emerging treatments for vitiligo, check out Drug Pipelines or Trials Hub sections of our website.

We also recommend reading our exclusive Vitiligo Drug Pipeline Analysis and Market Insights

 



      FAQOther Questions

      • Which therapy has minimal side-effects?

        Dead Sea climatotherapy is a unique and highly effective treatment option for vitiligo, offering a top-tier safety profile and natural therapeutic benefits. Its combination of p...

      • Is it Bitiligo? Vitaligo? Veteligo?

        There are so many different ways that people try and spell or even pronounce Vitiligo.  Here are some common mis-spellings: bitiligo, vitigo, vitaligo, vitilago, vitiglio, vita...

      • PTSD in Vitiligo?

        Living with vitiligo often involves more than managing visible skin changes. Many individuals face discrimination, social stigma, and feelings of isolation, leading to emotional...